Immunomedics (IMMU) - moderated Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Immunomedics (IMMU) - moderated

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

Recommended by:

jargonweary

jhcimmu

From: erickerickson	11/18/2024 8:57:20 AM
	2 Recommendations Read Replies (1) of 63305

Cassava Sciences Appoints Freda Nassif as Chief Commercial Officer "...She joins our company at a critical time, ahead of the release of topline results from RETHINK-ALZ, our first Phase 3 trial for simufilam, expected by the end of 2024, and potential product launch..." Well, reading tea leaves here, they're going all in on a positive readout and at least one person is willing to change jobs to be part of it. I'm curious how many options she got ;) I wouldn't bet the farm on this news, but least it's not negative. OTOH, they're not advertising hiring. Really, no change, we're approaching a binary event and holding our collective breath...

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next